Technology behind Covid tests to be developed to spot diabetes and Lyme disease
Aberdeen-based Vertebrate Antibodies Ltd is working with US biotech firm Innova Medical Group.
Experts who created the technology behind Covid tests at the height of the pandemic have joined forces with a US biotech firm to develop tests for other conditions such as diabetes and Lyme disease.
Formed by a group of research scientists at the University of Aberdeen, Vertebrate Antibodies Ltd (VAL) has secured investment with Innova Medical Group (IMG) to form a new holding company, EpitogenX.
EpitogenX aims to develop lab-based diagnostic tests for Lyme disease and diabetes, which are notoriously difficult to diagnose early enough to enable timely intervention.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.